Sterile Endotracheal Tube Market Report 2024

This Sterile Endotracheal Tube market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The sterile endotracheal tube market size has grown strongly in recent years. It will grow from $2.02 billion in 2023 to $2.14 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth observed during the historic period can be attributed to several factors, the rising demand for reliable intubation, enhanced understanding of airway management, increased awareness of infection control, improvements in patient safety protocols, and a greater focus on patient-centered care approaches.

The sterile endotracheal tube market size is expected to see strong growth in the next few years. It will grow to $2.76 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The projected growth in the forecast period can be attributed to several factors, the expansion of healthcare infrastructure, increased emergency medical services (EMS), a rise in chronic obstructive pulmonary disease (COPD), advancements in disposable endotracheal tubes, and evolving regulatory changes. Key trends expected during this period include the development of enhanced materials and coatings, improved visualization techniques, customization and personalization options, advanced safety features, and innovations in ergonomics and user experience.

The increasing prevalence of chronic respiratory conditions is expected to drive growth in the sterile endotracheal tube market. Chronic respiratory conditions are long-term diseases that impact the lungs and respiratory system, leading to ongoing breathing difficulties. Factors contributing to the rise in these conditions include elevated environmental pollution, higher smoking rates, an aging population, sedentary lifestyles, climate change, occupational hazards, and socio-economic disparities. Sterile endotracheal tubes are essential for managing chronic respiratory conditions as they ensure a clean airway for mechanical ventilation and help reduce the risk of infection. For example, a report from the Australian Institute of Health and Welfare, published in June 2024, highlighted 56,600 emergency department visits for asthma, equating to 230 visits per 100,000 people. Additionally, in 2022, respiratory conditions were a factor in 54,776 deaths, or 211 deaths per 100,000 population, making up 29% of all deaths in the 2020-21 period. As a result, the growing incidence of chronic respiratory conditions is fueling the demand for sterile endotracheal tubes.

Key players in the sterile endotracheal tube market are focusing on developing advanced solutions, such as endotracheal tube holders, to improve patient care and intubation procedures. An endotracheal tube holder is a medical device designed to secure and stabilize an endotracheal tube once it has been placed in the patient's trachea. For example, in June 2022, Dale Medical Products Inc., a U.S.-based manufacturer of specialty medical devices, introduced the BreezeLock Endotracheal Tube Holder. This new holder features a soft, flexible neckband without hard plastic components, similar to the Stabilock model. Notably, the BreezeLock includes a Tube Track that facilitates easy repositioning of the endotracheal tube while ensuring continued access for oral care.

In January 2022, ICU Medical Inc., a U.S.-based medical company, acquired Smiths Medical from Smiths Group plc for an undisclosed amount. This acquisition aligns with ICU Medical's strategy to enhance its position in the medical device market. By acquiring Smiths Medical, ICU Medical aims to expand its product range, increase its global presence, and leverage Smiths Medical’s innovative technologies to better support healthcare providers and patients worldwide. Smiths Medical is known for its contributions to the sterile endotracheal tube market.

Major companies operating in the sterile endotracheal tube market are Medtronic plc, Cook Medical Incorporated, Teleflex Incorporated, Zoll Medical Corporation, Hollister Incorporated, Avanos Medical Inc., Ambu A/S, Intersurgical Inc., Vyaire Medical Inc., Angiplast Pvt Ltd., Amsino International Inc., Inovet, GPC Medical Ltd., C. R. Bard Inc., Steroplast Healthcare Limited, Hitec Medical Co Ltd., Sterimed Group, Neurovision Medical Products Inc., Novo Klinik-Service GmbH, Well Lead Medical Co Ltd.

North America was the largest region in the sterile endotracheal tube market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile endotracheal tube market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sterile endotracheal tube market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A sterile endotracheal tube is a medical device used to secure and maintain an airway for patients who cannot breathe independently or require mechanical ventilation. It is inserted into the trachea to ensure an open airway and support mechanical ventilation while preventing infection through its sterile packaging and handling.

The primary types of sterile endotracheal tubes include no-capsules, olive sacs, and columnar sacs. A no-capsules sterile endotracheal tube is designed without additional coatings or capsules and is used for airway management during medical procedures. Its applications include emergency treatment, therapy, and various other medical uses. These tubes are used by end users such as clinics, hospitals, ambulatory surgical centers, and similar healthcare facilities.

The sterile endotracheal tube market research report is one of a series of new reports that provides sterile endotracheal tube market statistics, including the sterile endotracheal tube industry's global market size, regional shares, competitors with a sterile endotracheal tube market share, detailed sterile endotracheal tube market segments, market trends and opportunities, and any further data you may need to thrive in the sterile endotracheal tube industry. This sterile endotracheal tube market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sterile endotracheal tube market consists of sales of endotracheal tubes, lubricants, suction catheters, syringes, and airway management kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.